Clinical Trial Update: A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial of ferumoxytol for iron deficiency anemia in pediatric patients with nondialysis-dependent chronic kidney disease was terminated; results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: AMAG Pharmaceuticals, Inc. | Conditions: Iron Deficiency Anemia, Nondialysis-dependent Chronic Kidney Disease | Phase 3 | Status: TERMINATED | Results posted: 2017-11-06